Pharmacotherapy Publications Inc

“The organization amended their by-laws and articles of incorporation and restated the name of the organization as accp foundation, ltd. The organization was formerly known as pharmacotherapy publications, inc. See attached articles of incorporation and articles of merger.”

“Organization's process to review form 990: the return will be reviewed by the full board of directors. A copy of the return will be maintained for public inspection.”

“Any potential author, editor, editorial board member, reviewer, or contributor to an accp foundation publication or program will be evaluated to determine whether the potential for excessive real or perceived conflict of interest exists. If this evaluation determines that conflict of interest does exist, that individual will be excused from duty or participation in that project.”

“Governing documents are available for public inspection upon request and posted on the secretary of state website of the commonwealth of massachussets.”

“Effective december 1, 2024, under an agreement of merger, pharmacotherapy publications, inc. (ein 04-2720360) merged with accp-foundation (ein 43-1717075). The merged organization now operates under the name of accp foundation, ltd. The focus of accp foundation, ltd. Will continue to be contained within the defining goals of accp-f and ppi: to publish a scientific journal with the education, review, and publication of research and study results of drugs and the interaction of pharmaceuticals; and support and disseminate pharmacotherapeutic and clinical pharmacy research, scholarship, and practice innovation to advance human health and other charitable, research, and scientific purposes.”

“Effective december 1, 2024, under an agreement of merger, pharmacotherapy publications, inc. (ein 04-2720360) merged with accp-foundation (ein 43-1717075). The merged organization now operates under the name of accp foundation, ltd. The focus of accp foundation, ltd. Will continue to be contained within the defining goals of accp-f and ppi: to publish a scientific journal with the education, review, and publication of research and study results of drugs and the interaction of pharmaceuticals; and support and disseminate pharmacotherapeutic and clinical pharmacy research, scholarship, and practice innovation to advance human health and other charitable, research, and scientific purposes.”

“Contracted services: program service expenses 55,366. Management and general expenses 18,456. Fundraising expenses 0. Total expenses 73,822. Jaccp editors: program service expenses 2,759. Management and general expenses 0. Fundraising expenses 0. Total expenses 2,759. Scientific editors committee: program service expenses 7,737. Management and general expenses 0. Fundraising expenses 0. Total expenses 7,737. Board of directors: program service expenses 0. Management and general expenses 43,693. Fundraising expenses 0. Total expenses 43,693. Consulting: program service expenses 0. Management and general expenses 2,000. Fundraising expenses 0. Total expenses 2,000. Development editors: program service expenses 131,251. Management and general expenses 0. Fundraising expenses 0. Total expenses 131,251. Manuscript scientific editing: program service expenses 151,087. Management and general expenses 0. Fundraising expenses 0. Total expenses 151,087. Overhead: program service expenses 0. Management and general expenses 36,333. Fundraising expenses 0. Total expenses 36,333. Bank charges/misc exp: program service expenses 0. Management and general expenses 141. Fundraising expenses 0. Total expenses 141. Org dues ri director: program service expenses 0. Management and general expenses 767. Fundraising expenses 0. Total expenses 767. Legacy fund development: program service expenses 0. Management and general expenses 750. Fundraising expenses 0. Total expenses 750.”

“Net assets from accp-foundation merger 3,411,552.”